JP2022508642A5 - - Google Patents
Info
- Publication number
- JP2022508642A5 JP2022508642A5 JP2021544096A JP2021544096A JP2022508642A5 JP 2022508642 A5 JP2022508642 A5 JP 2022508642A5 JP 2021544096 A JP2021544096 A JP 2021544096A JP 2021544096 A JP2021544096 A JP 2021544096A JP 2022508642 A5 JP2022508642 A5 JP 2022508642A5
- Authority
- JP
- Japan
- Prior art keywords
- independently
- heteroatoms
- membered
- ring containing
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024179311A JP2025020149A (ja) | 2018-10-05 | 2024-10-11 | モノマーおよびマルチマー抗ｈｂｖ薬 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862741822P | 2018-10-05 | 2018-10-05 | |
| US62/741,822 | 2018-10-05 | ||
| PCT/US2019/054790 WO2020072955A1 (en) | 2018-10-05 | 2019-10-04 | Monomer and multimeric anti-hbv agents |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024179311A Division JP2025020149A (ja) | 2018-10-05 | 2024-10-11 | モノマーおよびマルチマー抗ｈｂｖ薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022508642A JP2022508642A (ja) | 2022-01-19 |
| JP2022508642A5 true JP2022508642A5 (https=) | 2023-06-27 |
| JP7648528B2 JP7648528B2 (ja) | 2025-03-18 |
Family
ID=70055532
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021544096A Active JP7648528B2 (ja) | 2018-10-05 | 2019-10-04 | モノマーおよびマルチマー抗ｈｂｖ薬 |
| JP2024179311A Pending JP2025020149A (ja) | 2018-10-05 | 2024-10-11 | モノマーおよびマルチマー抗ｈｂｖ薬 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024179311A Pending JP2025020149A (ja) | 2018-10-05 | 2024-10-11 | モノマーおよびマルチマー抗ｈｂｖ薬 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20230056135A1 (https=) |
| EP (1) | EP3860991A4 (https=) |
| JP (2) | JP7648528B2 (https=) |
| KR (2) | KR20250107952A (https=) |
| CN (1) | CN113166115A (https=) |
| AU (1) | AU2019355218B2 (https=) |
| BR (1) | BR112021006403A2 (https=) |
| CA (1) | CA3113109A1 (https=) |
| IL (1) | IL281698A (https=) |
| MX (1) | MX2021003150A (https=) |
| PH (1) | PH12021550632A1 (https=) |
| SG (1) | SG11202102661UA (https=) |
| WO (1) | WO2020072955A1 (https=) |
| ZA (1) | ZA202102589B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230056135A1 (en) * | 2018-10-05 | 2023-02-23 | Emory University | Monomer and multimeric anti-hbv agents |
| MX2021012105A (es) * | 2019-04-03 | 2021-11-03 | Aligos Therapeutics Inc | Compuestos de pirrol. |
| GB202105000D0 (en) * | 2021-04-08 | 2021-05-26 | Pathios Therapeutics Ltd | Compounds |
| WO2022156758A1 (zh) * | 2021-01-22 | 2022-07-28 | 广东东阳光药业有限公司 | 新型酰胺吡咯类化合物及其在药物中的用途 |
| CN118974014B (zh) * | 2022-03-17 | 2026-01-27 | 成都微芯药业有限公司 | 吡咯酰胺类化合物及其制备方法和用途 |
| CN116120219A (zh) * | 2022-12-27 | 2023-05-16 | 吉斯凯(苏州)制药有限公司 | 一种多取代吡咯类化合物及其制备方法和在制备hbv衣壳蛋白抑制剂中的应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPP913999A0 (en) * | 1999-03-12 | 1999-04-01 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| EP1526852A1 (en) * | 2002-07-25 | 2005-05-04 | Pharmacia Italia S.p.A. | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| US9242981B2 (en) * | 2010-09-16 | 2016-01-26 | Merck Sharp & Dohme Corp. | Fused pyrazole derivatives as novel ERK inhibitors |
| JP5977347B2 (ja) * | 2011-07-01 | 2016-08-24 | バルーク エス．ブルームバーグ インスティテュート | Ｈｂｖ感染に対する抗ウイルス剤としてのスルファモイルベンズアミド誘導体 |
| KR102271574B1 (ko) * | 2012-08-28 | 2021-07-01 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | 설파모일-아릴아미드 및 b형 간염 치료제로서의 그 용도 |
| HK1215030A1 (zh) * | 2012-11-09 | 2016-08-12 | Indiana University Research And Technology Corporation | 用於hbv組裝效應劑的替代用途 |
| BR112015015584A2 (pt) * | 2012-12-27 | 2017-12-12 | Baruch S Blumberg Inst | novos agentes antivirais contra infecção por hbv |
| HRP20180791T1 (hr) * | 2013-07-25 | 2018-09-07 | Janssen Sciences Ireland Uc | Glioksamid supstituirani derivati pirolamida i njihova uporaba kao lijekova za liječenje hepatitisa b |
| CN106459061B (zh) * | 2014-05-30 | 2020-01-21 | 齐鲁制药有限公司 | 作为hbv抑制剂的二氢嘧啶并环衍生物 |
| WO2016109684A2 (en) * | 2014-12-30 | 2016-07-07 | Novira Therapeutics, Inc. | Derivatives and methods of treating hepatitis b infections |
| CN106317055A (zh) * | 2015-07-02 | 2017-01-11 | 中国科学院上海药物研究所 | 一类具有激酶抑制活性的化合物、制备方法和用途 |
| CO2018009382A2 (es) * | 2016-03-09 | 2018-09-20 | Univ Emory | Eliminación del virus de la hepatitis b con agentes antivirales |
| JOP20190024A1 (ar) * | 2016-08-26 | 2019-02-19 | Gilead Sciences Inc | مركبات بيروليزين بها استبدال واستخداماتها |
| WO2019185016A1 (zh) * | 2018-03-30 | 2019-10-03 | 正大天晴药业集团股份有限公司 | 含有n杂五元环的衣壳蛋白装配抑制剂、其药物组合物和用途 |
| JP2021527638A (ja) * | 2018-06-11 | 2021-10-14 | ベナトルクス ファーマシューティカルズ，インク． | Ｂ型肝炎カプシドアセンブリモジュレーター |
| CN112469716B (zh) * | 2018-06-28 | 2024-07-16 | 深圳扬厉医药技术有限公司 | 二氢嘧啶衍生物及其用途 |
| US20230056135A1 (en) * | 2018-10-05 | 2023-02-23 | Emory University | Monomer and multimeric anti-hbv agents |
-
2019
- 2019-10-04 US US17/281,940 patent/US20230056135A1/en active Pending
- 2019-10-04 CA CA3113109A patent/CA3113109A1/en active Pending
- 2019-10-04 WO PCT/US2019/054790 patent/WO2020072955A1/en not_active Ceased
- 2019-10-04 SG SG11202102661UA patent/SG11202102661UA/en unknown
- 2019-10-04 MX MX2021003150A patent/MX2021003150A/es unknown
- 2019-10-04 KR KR1020257021884A patent/KR20250107952A/ko active Pending
- 2019-10-04 BR BR112021006403A patent/BR112021006403A2/pt unknown
- 2019-10-04 AU AU2019355218A patent/AU2019355218B2/en active Active
- 2019-10-04 KR KR1020217012512A patent/KR20210072015A/ko active Pending
- 2019-10-04 JP JP2021544096A patent/JP7648528B2/ja active Active
- 2019-10-04 EP EP19868793.1A patent/EP3860991A4/en active Pending
- 2019-10-04 CN CN201980081049.5A patent/CN113166115A/zh active Pending
-
2021
- 2021-03-19 PH PH12021550632A patent/PH12021550632A1/en unknown
- 2021-03-21 IL IL281698A patent/IL281698A/en unknown
- 2021-04-19 ZA ZA2021/02589A patent/ZA202102589B/en unknown
-
2024
- 2024-10-11 JP JP2024179311A patent/JP2025020149A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022508642A5 (https=) | ||
| JP2019507774A5 (https=) | ||
| JP2023500328A5 (https=) | ||
| JP2024543976A5 (https=) | ||
| WO2018013597A4 (en) | 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors | |
| JP2021534124A5 (https=) | ||
| RU2397171C2 (ru) | 9-замещенное производное 8-оксоаденина и лекарственное средство | |
| RU2419626C2 (ru) | Соединения и композиции в качестве ингибиторов протеазы, активирующей каналы | |
| JP2022505987A5 (https=) | ||
| RU2020123241A (ru) | Полициклические соединения в качестве аллостерических ингибиторов shp2 | |
| JP2014520822A5 (https=) | ||
| RU2010136665A (ru) | Новые пиридиноны и пиридазиноны | |
| RU2009102252A (ru) | Хиноксалинилмакроциклические ингибиторы серинпротеазы вируса гепатита с | |
| JP2016509591A5 (https=) | ||
| EA200900358A1 (ru) | Энантиомерно чистые фосфоиндолы в качестве ингибиторов hiv | |
| RU2008136187A (ru) | Новое производное кумарина, обладающее противоопухолевой активностью | |
| JP2008510691A5 (https=) | ||
| AR060994A1 (es) | Derivados de triazolopirazina | |
| RU2017145650A (ru) | Ингибиторы тирозинкиназы брутона | |
| JP2018502891A5 (https=) | ||
| RU2011146145A (ru) | Противовирусные соединения | |
| JP2021534108A5 (https=) | ||
| JP2023518411A5 (https=) | ||
| RU2012102094A (ru) | Новые азабициклогексаны | |
| RU2015104969A (ru) | Производные пиридинона в качестве ингибиторов трансглутаминазы тканей |